Penn's Patent Pipeline Costs

The University of Pennsylvania has filed nearly 5,000 patent applications since September 2012, with the majority relating to medical science. Each of these filings requires a financial investment that ranges from $15,000 to $30,000, a cost fully covered by the Penn Center for Innovation.

The path from a laboratory discovery to a formally issued patent is a lengthy procedure. The average utility patent application spends roughly two years pending at the United States Patent and Trademark Office. During this period, the initial application is frequently rejected in an Official Action letter. The university's patent attorney then writes a response, initiating a back-and-forth exchange known as patent prosecution. This legal dialogue can continue for several years before the USPTO agrees to issue the patent.

Benjamin Dibling, the managing director of the Penn Center for Innovation, stated that the center aims to maximize the impact of the university's research. He explained that commercialization serves as a parallel path to traditional academic publication. The center evaluates inventions to determine if they have the potential to become new products, services, or the foundation for new businesses. The primary incentive for seeking patent protection is securing an exclusive market position for a fixed duration, preventing unrelated companies from releasing identical competing products.

The process begins when researchers submit an invention disclosure. This document is mandatory for any invention or discovery that may be patentable, provided federal or sponsored research funds were involved. PCI then relies on outside patent counsel from various firms to handle the legal work. The Office of General Counsel signs off on these external collaborations but typically does not intervene in the day-to-day prosecution. Dibling noted that the legal office is more likely to become involved if a patent infringement lawsuit arises.

Since the Leahy-Smith America Invents Act took effect in 2012, Penn has been able to file patents on behalf of its researchers. Filings by Penn inventors have climbed steadily since that point and have remained above 400 annually since 2021. Most granted patents fall under Cooperative Patent Classification sections A and C. Within those categories, three subsections dominate the output: antineoplastic agents, T-cells, and viral vectors, with the latter accounting for 413 patents.

The university owns inventions created by Penn personnel, including faculty, postdocs, and graduate students supported by research grants. PCI actively manages licensing rights and takes direct responsibility for maintaining and protecting these patents. A spokesperson for PCI clarified in a statement that securing a patent does not limit the academic freedom of researchers to use the patented invention for academic purposes.

Dibling acknowledged that the patent budget is finite. He noted that some faculty members do not realize how expensive the filing process is. The center does not patent every commercially valuable technology, recognizing that some inventions hold value without formal protection. Only a handful of 2025 and 2026 filings are currently publicly visible, as applications typically remain confidential for 18 months after the initial provisional filing.